Z-0905-2022 Class II Terminated

Recalled by Stanbio Laboratory, LP — Boerne, TX

FDA device recall Z-0905-2022 was initiated by Stanbio Laboratory, LP on Mar 16, 2022 and is designated Class II. Reason for recall: The device was being marketed as an IVD without a 510(k). Therefore, performance characteristics of these breast milk analyzers have not been adequately validated. An erroneous result could lead to… The recall status is terminated (terminated Jan 2, 2025). Affected quantity: 50.

Recall details

Product Type
Devices
Report Date
Apr 20, 2022
Initiation Date
Mar 16, 2022
Termination Date
Jan 2, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
50

Product description

Separation Technology Creamatocrit Plus, Catalog Number: 100-146

Reason for recall

The device was being marketed as an IVD without a 510(k). Therefore, performance characteristics of these breast milk analyzers have not been adequately validated. An erroneous result could lead to sub-optimal nutrition supplementation for patients (infants)

Distribution pattern

US Nationwide Distribution CA, TX, OK, SD, IL, NV, MO, FL, WA, KY, WI, PA, NC, GA, MD, MN

Code information

Sold between 2019 and 2021

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0905-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0905-2022. Report a data issue: hello@regdatalab.com.